Abstract

Previous studies have shown that necrostatin-1 (Nec-1) supplementation improved the viability of murine islets following exposure to nitric oxide, increased the survival of human islets during hypoxic culture, and augmented the maturation of pre-weaned porcine islets (PPIs) after 7 days of tissue culture. A limitation of these studies is that only one concentration of Nec-1 was used, and no studies have determined the optimal dose of Nec-1 for PPIs. Thus, the present study examined the effects of Nec-1 on PPIs at four different doses—0, 25, 50, 100, and 200 μM—after 7 days of tissue culture when supplemented on day 3. PPIs were isolated from pancreata of pre-weaned Yorkshire piglets (8–15 days old) and cultured in a specific islet maturation media added with Nec-1 on day 3 of tissue culture at 4 different doses—0, 25, 50, 100, and 200 μM (n = 6 for each dose). After 7 days of tissue culture, islets were assessed for recovery, viability, endocrine cellular content, GLUT2 expression in beta cells, and insulin secretion after glucose challenge. Nec-1 did not affect the viability of both intact islets and dissociated islets cells during tissue culture regardless of doses. Islets cultured in media supplemented with Nec-1 at 100 μM, but not 25, 50, or 200 μM, had a significantly higher recovery, composition of endocrine cells, GLUT2 expression in beta cells, and insulin secretion capacity than control islets cultured in media without Nec-1 supplementation. Moreover, culturing islets in 200 μM Nec-1 supplemented media not only failed to improve the insulin release but resulted in a lower glucose-induced insulin stimulation index compared to islets cultured in media added with 100 μM Nec-1. Xenotransplantation using porcine islets continues to demonstrate scientific advances to justify this area of research. Our findings indicate that Nec-1 supplementation at 100 μM was most effective to enhance the in vitro maturation of PPIs during tissue culture.

Highlights

  • Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by the gradual destruction of insulin-secreting beta cells in pancreatic islets [1]

  • The recovery of islets cultured in media supplemented with 100 μM Nec-1 was significantly higher than control islets on day 7 of tissue culture (p < .01, Fig 1)

  • Islets cultured in media added with 100 μM Nec-1 had a significantly enhanced insulin-releasing capacity after incubation in L1, H, and H+ glucose media compared to islets cultured in 25 μM Nec-1 supplemented media (p < .05 for all three different glucose media, Fig 8A)

Read more

Summary

Introduction

Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by the gradual destruction of insulin-secreting beta cells in pancreatic islets [1]. The conventional treatment for T1DM involves daily subcutaneous injections of insulin [4]. This therapy can manage the disease, the increased risk of hypoglycemic episodes, treatment’s inducement of pain, and requirement of multiple doses a day can deter patients from utilizing the treatment correctly [5, 6]. In the search for an alternative treatment for T1DM, islet allotransplantation has been shown as a potential therapy to restore glucose homeostasis in patients with T1DM [7]. The universal implementation of islet allotransplantation has been hindered by the limited availability of suitable cadaveric donors and high-quality viable human islets [9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call